Sort
82,697 grants matching “vaccine development”
Genetically Attenuated PfSPZ Malaria Vaccine
$999,996Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2016 · AI
Plasmodium Falciparum Whole Sporozoite Malaria Vaccine
$999,995Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2013 · AI
Plasmodium Falciparum Whole Sporozoite Malaria Vaccine
$999,995Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2015 · AI
Genetically Attenuated PfSPZ Malaria Vaccine
$999,994Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2015 · AI
Plasmodium Falciparum Whole Sporozoite Malaria Vaccine
$999,994Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2014 · AI
Recombinant Outer Membrane Vesicles as a Novel Adjuvant for a Malaria Vaccine
$999,993Christopher Locher · Versatope Therapeutics, Inc. · R44 · FY2025 · AI
Optimizing SIV reservoir depletion by Tendel bsAb-98
$999,991Ellen Elizabeth Sparger · Tendel Therapies Inc. · R44 · FY2025 · AI
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine
$999,987Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
$999,986Michelle M. Butler · Microbiotix, Inc · R44 · FY2019 · AI
Annual Estimates of Influenza Vaccine Effectiveness: Davidson County, TN
$999,985Marie R Griffin · Vanderbilt University · U18 · FY2010 · IP
Attenuated Malaria Sporozoite Vaccine
$999,981Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2007 · AI
Attenuated Malaria Sporozoite Vaccine
$999,980Sanaria, Inc. · R44 · FY2005 · AI
ST-246 treatment of smallpox vaccine-related adverse events
$999,979Douglas W. Grosenbach · Siga Technologies, Inc. · R44 · FY2010 · AI
Screening for rAAV transduction enhancers
$999,976Terry L Bowlin · Microbiotix, Inc · R44 · FY2021 · AI
Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu
$999,975Elke Lipka · Tsrl, Inc. · R44 · FY2025 · AI
University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator
$999,971Jason J Rose · University Of Maryland Baltimore · U01 · FY2023 · GM
Human T Cell Lymphotropic Virus Vaccine Development
$999,969Glen N Barber · Stinginn, Llc · R42 · FY2024 · CA
Cryopreservation and delivery of sporozoite vaccine
$999,968Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2008 · AI
ST-246 treatment of smallpox vaccine-related adverse events
$999,960Douglas W. Grosenbach · Siga Technologies, Inc. · R44 · FY2009 · AI
PIPP Phase I: Computational Theory of the Co-evolution of Pandemics, (Mis)information, and Human Mindsets and Behavior
$999,955Peter Pirolli · Florida Institute For Human And Machine Cognition, Inc. · · FY2022 · SBE
Attenuated Malaria Sporozoite Vaccine
$999,955Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2006 · AI
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
$999,936Chamberlain Obialo · Accuhealth Technologies, Inc. · R44 · FY2022 · TR
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
$999,936Chamberlain Obialo · Accuhealth Technologies, Inc. · R44 · FY2023 · TR
Modeling the ecology of tissue-resident T cells
$999,932Andrew Yates · Columbia University Health Sciences · U01 · FY2021 · AI
Progressing PfSPZ vaccines for malaria to licensure and commercialization
$999,921Stephen Lev Hoffman · Sanaria, Inc. · SB1 · FY2023 · AI